Published in Lab Law Weekly, August 7th, 2009
The 'Vitacon Drug Valuation Model' is an Excel spreadsheet model that is intended to be used as an asset valuation and transaction strategy tool for the biopharmaceutical industry.
Analyze the risk-adjusted value of your new drug using a sensible number of input estimates and explore the deal structure that could satisfy any one of three starting points for a licensing bid.
With the Vitacon Drug Valuation Model , you can assess the risk-adjusted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.